Video Shorts

Daniel King, MD, PhD
1:27
What Does the Future Look Like for RAS-Targeted Therapies in Pancreatic Cancer?
a month ago
by
Daniel King, MD, PhD
Erika Hamilton, MD, FASCO
1:33
Highlighting the Efficacy of Tucatinib Plus Trastuzumab and Pertuzumab in HER2+ Breast Cancer
a month ago
by
Erika P. Hamilton, MD
Maurie Markman, MD
1:26
Maurie Markman, MD, Talks AI in Cancer Care
a month ago
by
Maurie Markman, MD
Adanma Ayanambakkam, MD, MS
0:31
Unpacking FIT-001 Data in RCC
a month ago
by
Adanma Ayanambakkam, MD, MS
Eleonora Teplinsky, MD, FASCO
0:30
Highlighting the Importance of Proactive Breast Cancer Care
a month ago
by
Eleonora Teplinsky, MD(+1 more)
Daniel Morillo, MD
1:24
Golcadomide Plus Rituximab Drives Durable Responses in R/R Follicular Lymphoma
a month ago
by
Daniel Morillo, MD
Maurie Markman, MD
1:40
Can AI Help Cure Cancer?
a month ago
by
Maurie Markman, MD
Millie Das, MD
0:40
Why the TKI May Stay On at Next Line in EGFR-Mutated NSCLC
a month ago
by
Millie Das, MD
Joshua Richter, MD
0:40
Joshua Richter, MD, Answers Rahul Banerjee, MD, FACP
a month ago
by
Joshua Richter, MD
Ferdinandos Skoulidis, MD, PhD, MRCP
0:51
KRASCENDO 170 Data With Divarasib and Pembrolizumab in Lung Cancer
a month ago
by
Ferdinandos Skoulidis, MD, PhD, MRCP
Joshua Richter, MD
0:35
Joshua Richter, MD, Discusses Multiple Myeloma Vaccines
a month ago
by
Joshua Richter, MD, Tisch Cancer Center at Mount Sinai
Brandon Huffman, MD
1:18
Phase 1 Efficacy Data With INCB161734 in Pancreatic Cancer
a month ago
by
Brandon Huffman, MD
Daniel Morillo, MD
0:48
Investigating Golcadomide in R/R Follicular Lymphoma
a month ago
by
Daniel Morillo, MD
Balazs Halmos, MD
0:28
Has Balazs Halmos, MD, ever met his celebrity look alike?
a month ago
by
Balazs Halmos, MD, MS
Ajaz M. Khan, MD, MBA, CPE
0:47
Spotlighting the lidERA Trial in Breast Cancer
a month ago
by
Ajaz M. Khan, MD, MBA, CPE
Madhur K. Garg, MD, MBA, MBBS
2:03
Exploring the Use of Proton Therapy in Head and Neck Cancer
a month ago
by
Madhur Garg, MD, MBA, FACR
Alessandro A. Viansone, MD
1:58
Highlighting Potential Future Updates to the HER2+ Breast Cancer Treatment Paradigm
a month ago
by
Alessandro A. Viansone, MD
Where Iberdomide Plus Daratumumab and Dexamethasone Fits in the R/R Myeloma Paradigm
1:15
Where Iberdomide Plus Daratumumab and Dexamethasone Fits in the R/R Myeloma Paradigm
a month ago
by
Rahul Banerjee, MD
Meredith Pelster, MD, MSCI
1:46
Exploring Atebimetinib in Metastatic Pancreatic Cancer
a month ago
by
Meredith Pelster, MD, MSCI
Nan Chen, MD
0:31
Managing Sacituzumab Govitecan–Related AEs in Breast Cancer
a month ago
by
Nan Chen, MD
Sara Nunnery, MD, MSCI, and Sarah B. Sunshine, MD
0:54
Dry Eye vs ADC-Related AEs in Breast Cancer
a month ago
by
Sara Nunnery, MD, MSCI(+1 more)
Toon Van Gorp, MD, PhD
0:44
PFS Data With TUB-040 in Platinum-Resistant Ovarian Cancer
a month ago
by
Toon Van Gorp, MD, PhD
Erman Akkus, MD
0:41
One Second-line Therapy Trial Still Needed in HCC
a month ago
by
Erman Akkus, MD
Sara M. Tolaney, MD, MPH
1:18
The Implications of Biomarker Analyses With Sacituzumab Govitecan in TNBC
a month ago
by
Sara M. Tolaney, MD, MPH
William J. Phillips, MD
1:03
Exploring Real-World Dose Reductions of RET Inhibitors in RET+ NSCLC
a month ago
by
William Phillips, MD
Jordyn Silverstein, MD, MSc
1:15
Updated Efficacy Findings With Abemaciclib and Hormonal Therapy in Gynecologic Cancers
a month ago
by
Jordyn Silverstein, MD
Rafael Fonseca, MD, discusses the evolution of molecular testing in multiple myeloma and its role in risk stratification and treatment decision-making.
1:13
Navigating Molecular Testing in Multiple Myeloma
a month ago
by
Rafael Fonseca, MD
Daniel Boiarsky, MD
1:20
Exploring the Potential Role of CD24 in Lung Cancer
a month ago
by
Daniel Boiarsky, MD
Sara Nunnery, MD, MSCI, and Sarah B. Sunshine, MD
0:59
The Role of Optometry Referrals in the Breast Cancer ADC Treatment Plan
a month ago
by
Sara Nunnery, MD, MSCI(+1 more)
Maurie Markman, MD
1:01
Public Libraries as a Resource for Cancer Information
a month ago
by
Maurie Markman, MD